Global Kidney Disease Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Kidney Disease Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Kidney Disease Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Kidney Disease Drugs by Country/Region, 2017, 2022 & 2028

2.2 Kidney Disease Drugs Segment by Type

2.2.1 Tablets

2.2.2 Capsule

2.2.3 Other

2.3 Kidney Disease Drugs Sales by Type

2.3.1 Global Kidney Disease Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Kidney Disease Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Kidney Disease Drugs Sale Price by Type (2017-2022)

2.4 Kidney Disease Drugs Segment by Application

2.4.1 Chronic Glomerulonephritis

2.4.2 Nephrotic Syndrome

2.4.3 Chronic Renal Failure

2.4.4 Kidney Stones

2.4.5 Renal Cyst (polycystic Kidney)

2.4.6 Diabetic Nephropathy

2.4.7 Hypertensive Nephropathy

2.4.8 Purpura Nephritis

2.4.9 Lupus Nephritis

2.4.10 Pediatric Kidney Disease

2.5 Kidney Disease Drugs Sales by Application

2.5.1 Global Kidney Disease Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Kidney Disease Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Kidney Disease Drugs Sale Price by Application (2017-2022)

3 Global Kidney Disease Drugs by Company

3.1 Global Kidney Disease Drugs Breakdown Data by Company

3.1.1 Global Kidney Disease Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Kidney Disease Drugs Sales Market Share by Company (2020-2022)

3.2 Global Kidney Disease Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Kidney Disease Drugs Revenue by Company (2020-2022)

3.2.2 Global Kidney Disease Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Kidney Disease Drugs Sale Price by Company

3.4 Key Manufacturers Kidney Disease Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Kidney Disease Drugs Product Location Distribution

3.4.2 Players Kidney Disease Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Kidney Disease Drugs by Geographic Region

4.1 World Historic Kidney Disease Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Kidney Disease Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Kidney Disease Drugs Annual Revenue by Geographic Region

4.2 World Historic Kidney Disease Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Kidney Disease Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Kidney Disease Drugs Annual Revenue by Country/Region

4.3 Americas Kidney Disease Drugs Sales Growth

4.4 APAC Kidney Disease Drugs Sales Growth

4.5 Europe Kidney Disease Drugs Sales Growth

4.6 Middle East & Africa Kidney Disease Drugs Sales Growth

5 Americas

5.1 Americas Kidney Disease Drugs Sales by Country

5.1.1 Americas Kidney Disease Drugs Sales by Country (2017-2022)

5.1.2 Americas Kidney Disease Drugs Revenue by Country (2017-2022)

5.2 Americas Kidney Disease Drugs Sales by Type

5.3 Americas Kidney Disease Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Kidney Disease Drugs Sales by Region

6.1.1 APAC Kidney Disease Drugs Sales by Region (2017-2022)

6.1.2 APAC Kidney Disease Drugs Revenue by Region (2017-2022)

6.2 APAC Kidney Disease Drugs Sales by Type

6.3 APAC Kidney Disease Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Kidney Disease Drugs by Country

7.1.1 Europe Kidney Disease Drugs Sales by Country (2017-2022)

7.1.2 Europe Kidney Disease Drugs Revenue by Country (2017-2022)

7.2 Europe Kidney Disease Drugs Sales by Type

7.3 Europe Kidney Disease Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Kidney Disease Drugs by Country

8.1.1 Middle East & Africa Kidney Disease Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Kidney Disease Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Kidney Disease Drugs Sales by Type

8.3 Middle East & Africa Kidney Disease Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Kidney Disease Drugs

10.3 Manufacturing Process Analysis of Kidney Disease Drugs

10.4 Industry Chain Structure of Kidney Disease Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Kidney Disease Drugs Distributors

11.3 Kidney Disease Drugs Customer

12 World Forecast Review for Kidney Disease Drugs by Geographic Region

12.1 Global Kidney Disease Drugs Market Size Forecast by Region

12.1.1 Global Kidney Disease Drugs Forecast by Region (2023-2028)

12.1.2 Global Kidney Disease Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Kidney Disease Drugs Forecast by Type

12.7 Global Kidney Disease Drugs Forecast by Application

13 Key Players Analysis

13.1 GlaxoSmithKline

13.1.1 GlaxoSmithKline Company Information

13.1.2 GlaxoSmithKline Kidney Disease Drugs Product Offered

13.1.3 GlaxoSmithKline Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GlaxoSmithKline Main Business Overview

13.1.5 GlaxoSmithKline Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Kidney Disease Drugs Product Offered

13.2.3 Sanofi Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 Roche

13.3.1 Roche Company Information

13.3.2 Roche Kidney Disease Drugs Product Offered

13.3.3 Roche Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Roche Main Business Overview

13.3.5 Roche Latest Developments

13.4 Pfizer

13.4.1 Pfizer Company Information

13.4.2 Pfizer Kidney Disease Drugs Product Offered

13.4.3 Pfizer Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pfizer Main Business Overview

13.4.5 Pfizer Latest Developments

13.5 AstraZeneca

13.5.1 AstraZeneca Company Information

13.5.2 AstraZeneca Kidney Disease Drugs Product Offered

13.5.3 AstraZeneca Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 AstraZeneca Main Business Overview

13.5.5 AstraZeneca Latest Developments

13.6 Keryx Biopharmaceuticals

13.6.1 Keryx Biopharmaceuticals Company Information

13.6.2 Keryx Biopharmaceuticals Kidney Disease Drugs Product Offered

13.6.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Keryx Biopharmaceuticals Main Business Overview

13.6.5 Keryx Biopharmaceuticals Latest Developments

13.7 Kissei Pharmaceutical

13.7.1 Kissei Pharmaceutical Company Information

13.7.2 Kissei Pharmaceutical Kidney Disease Drugs Product Offered

13.7.3 Kissei Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Kissei Pharmaceutical Main Business Overview

13.7.5 Kissei Pharmaceutical Latest Developments

13.8 AbbVie

13.8.1 AbbVie Company Information

13.8.2 AbbVie Kidney Disease Drugs Product Offered

13.8.3 AbbVie Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 AbbVie Main Business Overview

13.8.5 AbbVie Latest Developments

13.9 Amgen

13.9.1 Amgen Company Information

13.9.2 Amgen Kidney Disease Drugs Product Offered

13.9.3 Amgen Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Amgen Main Business Overview

13.9.5 Amgen Latest Developments

13.10 Teva Pharmaceutical Industries

13.10.1 Teva Pharmaceutical Industries Company Information

13.10.2 Teva Pharmaceutical Industries Kidney Disease Drugs Product Offered

13.10.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Teva Pharmaceutical Industries Main Business Overview

13.10.5 Teva Pharmaceutical Industries Latest Developments

13.11 Tianjin Tongrentang Group

13.11.1 Tianjin Tongrentang Group Company Information

13.11.2 Tianjin Tongrentang Group Kidney Disease Drugs Product Offered

13.11.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Tianjin Tongrentang Group Main Business Overview

13.11.5 Tianjin Tongrentang Group Latest Developments

13.12 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical

13.12.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Company Information

13.12.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Offered

13.12.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Main Business Overview

13.12.5 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Latest Developments

13.13 Datong Liqun Pharmaceutical

13.13.1 Datong Liqun Pharmaceutical Company Information

13.13.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Product Offered

13.13.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Datong Liqun Pharmaceutical Main Business Overview

13.13.5 Datong Liqun Pharmaceutical Latest Developments

13.14 Hebei Ruisen Pharmaceutical

13.14.1 Hebei Ruisen Pharmaceutical Company Information

13.14.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Offered

13.14.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Hebei Ruisen Pharmaceutical Main Business Overview

13.14.5 Hebei Ruisen Pharmaceutical Latest Developments

13.15 Changxing Pharmaceutical

13.15.1 Changxing Pharmaceutical Company Information

13.15.2 Changxing Pharmaceutical Kidney Disease Drugs Product Offered

13.15.3 Changxing Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Changxing Pharmaceutical Main Business Overview

13.15.5 Changxing Pharmaceutical Latest Developments

13.16 zhejiang Shengbokang Pharmaceutical

13.16.1 zhejiang Shengbokang Pharmaceutical Company Information

13.16.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Offered

13.16.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 zhejiang Shengbokang Pharmaceutical Main Business Overview

13.16.5 zhejiang Shengbokang Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Kidney Disease Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Kidney Disease Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tablets

Table 4. Major Players of Capsule

Table 5. Major Players of Other

Table 6. Global Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 7. Global Kidney Disease Drugs Sales Market Share by Type (2017-2022)

Table 8. Global Kidney Disease Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global Kidney Disease Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global Kidney Disease Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 12. Global Kidney Disease Drugs Sales Market Share by Application (2017-2022)

Table 13. Global Kidney Disease Drugs Revenue by Application (2017-2022)

Table 14. Global Kidney Disease Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global Kidney Disease Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Kidney Disease Drugs Sales by Company (2020-2022) & (K Units)

Table 17. Global Kidney Disease Drugs Sales Market Share by Company (2020-2022)

Table 18. Global Kidney Disease Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Kidney Disease Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global Kidney Disease Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Kidney Disease Drugs Producing Area Distribution and Sales Area

Table 22. Players Kidney Disease Drugs Products Offered

Table 23. Kidney Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Kidney Disease Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Kidney Disease Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global Kidney Disease Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Kidney Disease Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Kidney Disease Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Kidney Disease Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global Kidney Disease Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Kidney Disease Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)

Table 35. Americas Kidney Disease Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas Kidney Disease Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Kidney Disease Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 39. Americas Kidney Disease Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 41. Americas Kidney Disease Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC Kidney Disease Drugs Sales by Region (2017-2022) & (K Units)

Table 43. APAC Kidney Disease Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC Kidney Disease Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Kidney Disease Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 47. APAC Kidney Disease Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 49. APAC Kidney Disease Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)

Table 51. Europe Kidney Disease Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe Kidney Disease Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Kidney Disease Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 55. Europe Kidney Disease Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 57. Europe Kidney Disease Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Kidney Disease Drugs Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Kidney Disease Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Kidney Disease Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Kidney Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Kidney Disease Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Kidney Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Kidney Disease Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Kidney Disease Drugs

Table 67. Key Market Challenges & Risks of Kidney Disease Drugs

Table 68. Key Industry Trends of Kidney Disease Drugs

Table 69. Kidney Disease Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Kidney Disease Drugs Distributors List

Table 72. Kidney Disease Drugs Customer List

Table 73. Global Kidney Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Kidney Disease Drugs Sales Market Forecast by Region

Table 75. Global Kidney Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Kidney Disease Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Kidney Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Kidney Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Kidney Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Kidney Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Kidney Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Kidney Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Kidney Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Kidney Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Kidney Disease Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Kidney Disease Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Kidney Disease Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Kidney Disease Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Kidney Disease Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Kidney Disease Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Kidney Disease Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Kidney Disease Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. GlaxoSmithKline Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. GlaxoSmithKline Kidney Disease Drugs Product Offered

Table 95. GlaxoSmithKline Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. GlaxoSmithKline Main Business

Table 97. GlaxoSmithKline Latest Developments

Table 98. Sanofi Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Sanofi Kidney Disease Drugs Product Offered

Table 100. Sanofi Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Sanofi Main Business

Table 102. Sanofi Latest Developments

Table 103. Roche Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Roche Kidney Disease Drugs Product Offered

Table 105. Roche Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Roche Main Business

Table 107. Roche Latest Developments

Table 108. Pfizer Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Pfizer Kidney Disease Drugs Product Offered

Table 110. Pfizer Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Pfizer Main Business

Table 112. Pfizer Latest Developments

Table 113. AstraZeneca Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. AstraZeneca Kidney Disease Drugs Product Offered

Table 115. AstraZeneca Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. AstraZeneca Main Business

Table 117. AstraZeneca Latest Developments

Table 118. Keryx Biopharmaceuticals Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Keryx Biopharmaceuticals Kidney Disease Drugs Product Offered

Table 120. Keryx Biopharmaceuticals Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Keryx Biopharmaceuticals Main Business

Table 122. Keryx Biopharmaceuticals Latest Developments

Table 123. Kissei Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Kissei Pharmaceutical Kidney Disease Drugs Product Offered

Table 125. Kissei Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Kissei Pharmaceutical Main Business

Table 127. Kissei Pharmaceutical Latest Developments

Table 128. AbbVie Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. AbbVie Kidney Disease Drugs Product Offered

Table 130. AbbVie Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. AbbVie Main Business

Table 132. AbbVie Latest Developments

Table 133. Amgen Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. Amgen Kidney Disease Drugs Product Offered

Table 135. Amgen Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Amgen Main Business

Table 137. Amgen Latest Developments

Table 138. Teva Pharmaceutical Industries Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. Teva Pharmaceutical Industries Kidney Disease Drugs Product Offered

Table 140. Teva Pharmaceutical Industries Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Teva Pharmaceutical Industries Main Business

Table 142. Teva Pharmaceutical Industries Latest Developments

Table 143. Tianjin Tongrentang Group Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Tianjin Tongrentang Group Kidney Disease Drugs Product Offered

Table 145. Tianjin Tongrentang Group Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Tianjin Tongrentang Group Main Business

Table 147. Tianjin Tongrentang Group Latest Developments

Table 148. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 149. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Offered

Table 150. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Main Business

Table 152. Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Latest Developments

Table 153. Datong Liqun Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 154. Datong Liqun Pharmaceutical Kidney Disease Drugs Product Offered

Table 155. Datong Liqun Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Datong Liqun Pharmaceutical Main Business

Table 157. Datong Liqun Pharmaceutical Latest Developments

Table 158. Hebei Ruisen Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 159. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Offered

Table 160. Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 161. Hebei Ruisen Pharmaceutical Main Business

Table 162. Hebei Ruisen Pharmaceutical Latest Developments

Table 163. Changxing Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 164. Changxing Pharmaceutical Kidney Disease Drugs Product Offered

Table 165. Changxing Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 166. Changxing Pharmaceutical Main Business

Table 167. Changxing Pharmaceutical Latest Developments

Table 168. zhejiang Shengbokang Pharmaceutical Basic Information, Kidney Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 169. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Offered

Table 170. zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 171. zhejiang Shengbokang Pharmaceutical Main Business

Table 172. zhejiang Shengbokang Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Kidney Disease Drugs

Figure 2. Kidney Disease Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Kidney Disease Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Kidney Disease Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Kidney Disease Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tablets

Figure 10. Product Picture of Capsule

Figure 11. Product Picture of Other

Figure 12. Global Kidney Disease Drugs Sales Market Share by Type in 2021

Figure 13. Global Kidney Disease Drugs Revenue Market Share by Type (2017-2022)

Figure 14. Kidney Disease Drugs Consumed in Chronic Glomerulonephritis

Figure 15. Global Kidney Disease Drugs Market: Chronic Glomerulonephritis (2017-2022) & (K Units)

Figure 16. Kidney Disease Drugs Consumed in Nephrotic Syndrome

Figure 17. Global Kidney Disease Drugs Market: Nephrotic Syndrome (2017-2022) & (K Units)

Figure 18. Kidney Disease Drugs Consumed in Chronic Renal Failure

Figure 19. Global Kidney Disease Drugs Market: Chronic Renal Failure (2017-2022) & (K Units)

Figure 20. Kidney Disease Drugs Consumed in Kidney Stones

Figure 21. Global Kidney Disease Drugs Market: Kidney Stones (2017-2022) & (K Units)

Figure 22. Kidney Disease Drugs Consumed in Renal Cyst (polycystic Kidney)

Figure 23. Global Kidney Disease Drugs Market: Renal Cyst (polycystic Kidney) (2017-2022) & (K Units)

Figure 24. Kidney Disease Drugs Consumed in Diabetic Nephropathy

Figure 25. Global Kidney Disease Drugs Market: Diabetic Nephropathy (2017-2022) & (K Units)

Figure 26. Kidney Disease Drugs Consumed in Hypertensive Nephropathy

Figure 27. Global Kidney Disease Drugs Market: Hypertensive Nephropathy (2017-2022) & (K Units)

Figure 28. Kidney Disease Drugs Consumed in Purpura Nephritis

Figure 29. Global Kidney Disease Drugs Market: Purpura Nephritis (2017-2022) & (K Units)

Figure 30. Kidney Disease Drugs Consumed in Lupus Nephritis

Figure 31. Global Kidney Disease Drugs Market: Lupus Nephritis (2017-2022) & (K Units)

Figure 32. Kidney Disease Drugs Consumed in Pediatric Kidney Disease

Figure 33. Global Kidney Disease Drugs Market: Pediatric Kidney Disease (2017-2022) & (K Units)

Figure 34. Global Kidney Disease Drugs Sales Market Share by Application (2017-2022)

Figure 35. Global Kidney Disease Drugs Revenue Market Share by Application in 2021

Figure 36. Kidney Disease Drugs Revenue Market by Company in 2021 ($ Million)

Figure 37. Global Kidney Disease Drugs Revenue Market Share by Company in 2021

Figure 38. Global Kidney Disease Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 39. Global Kidney Disease Drugs Revenue Market Share by Geographic Region in 2021

Figure 40. Global Kidney Disease Drugs Sales Market Share by Region (2017-2022)

Figure 41. Global Kidney Disease Drugs Revenue Market Share by Country/Region in 2021

Figure 42. Americas Kidney Disease Drugs Sales 2017-2022 (K Units)

Figure 43. Americas Kidney Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 44. APAC Kidney Disease Drugs Sales 2017-2022 (K Units)

Figure 45. APAC Kidney Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 46. Europe Kidney Disease Drugs Sales 2017-2022 (K Units)

Figure 47. Europe Kidney Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 48. Middle East & Africa Kidney Disease Drugs Sales 2017-2022 (K Units)

Figure 49. Middle East & Africa Kidney Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 50. Americas Kidney Disease Drugs Sales Market Share by Country in 2021

Figure 51. Americas Kidney Disease Drugs Revenue Market Share by Country in 2021

Figure 52. United States Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Canada Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Mexico Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Brazil Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. APAC Kidney Disease Drugs Sales Market Share by Region in 2021

Figure 57. APAC Kidney Disease Drugs Revenue Market Share by Regions in 2021

Figure 58. China Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Japan Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Korea Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Southeast Asia Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. India Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Australia Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Europe Kidney Disease Drugs Sales Market Share by Country in 2021

Figure 65. Europe Kidney Disease Drugs Revenue Market Share by Country in 2021

Figure 66. Germany Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. France Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. UK Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. Italy Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Russia Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 71. Middle East & Africa Kidney Disease Drugs Sales Market Share by Country in 2021

Figure 72. Middle East & Africa Kidney Disease Drugs Revenue Market Share by Country in 2021

Figure 73. Egypt Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 74. South Africa Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 75. Israel Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 76. Turkey Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 77. GCC Country Kidney Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 78. Manufacturing Cost Structure Analysis of Kidney Disease Drugs in 2021

Figure 79. Manufacturing Process Analysis of Kidney Disease Drugs

Figure 80. Industry Chain Structure of Kidney Disease Drugs

Figure 81. Channels of Distribution

Figure 82. Distributors Profiles